RIP Laura Buckley Noonan
Search
06 Sept 2025
Search
06 Sept 2025
Please allow ads as they help fund our trusted local news content.
Kindly add us to your ad blocker whitelist.
If you want further access to Ireland's best local journalism, consider contributing and/or subscribing to our free daily Newsletter .
Support our mission and join our community now.
To continue reading this article, you can subscribe for as little as €0.50 per week which will also give you access to all of our premium content and archived articles!
Alternatively, you can pay €0.50 per article, capped at €1 per day.
Thank you for supporting Ireland's best local journalism!
Covid-19 booster vaccines and treatments for coronavirus helped push Pfizer to a better-than-expected final quarter of 2022.
However, the pharmaceutical giant announced on Tuesday a 2023 forecast that starts off well below Wall Street forecasts.
In the recently completed fourth quarter, Pfizer booked nearly half of its 24.29 billion US dollars (£19.62 billion) in revenue from its top-selling Covid vaccine Comirnaty and another 1.8 billion dollars (£1.5 billion) from the treatment Paxlovid.
Overall, the drug-maker posted adjusted earnings of 1.14 dollars (92p) per share.
Analysts had forecast fourth-quarter earnings of 1.05 dollars (85p) per share on 24.38 billion dollars (£19.69 billion) in revenue, according to FactSet.
For the new year, Pfizer expects adjusted earnings to range between 3.25 dollars (£2.63) and 3.45 dollars (£2.79) per share.
Analysts expect earnings of 4.34 dollars (£3.50) per share for 2023, according to FactSet.
Shares in New York-based Pfizer Inc fell in early-morning trading on Tuesday.
Subscribe or register today to discover more from DonegalLive.ie
Buy the e-paper of the Donegal Democrat, Donegal People's Press, Donegal Post and Inish Times here for instant access to Donegal's premier news titles.
Keep up with the latest news from Donegal with our daily newsletter featuring the most important stories of the day delivered to your inbox every evening at 5pm.
This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.
